Name: Latest research reports of Alembic Pharmaceuticals Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alembic Pharmaceuticals Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

875.4500 -5.10 (-0.58%)

NSE Apr 25, 2025 15:31 PM

32.86% Fall from 52W High

Volume: 134.7K

Alembic Pharmaceuticals Ltd.

08 Nov 2023

875.45

-0.58%

Alembic Pharma (HOLD): Higher opex from new facilities to keep a lid on margins

Hold: Alembic Pharmaceuticals Ltd.

Target

BOB Capital Markets Ltd.

Q2 revenue ticked up 8% YoY as healthy sales in international markets supported by modest India business

Alembic Pharmaceutic.. has an average target of 959.00 from 4 brokers.